CWM
CRSP icon

CIBC World Markets’s CRISPR Therapeutics CRSP Stock Holding History

CIBC World Markets’s Portfolio CRSP Stock Details CRSP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		$302K Buy
+5,767
New +$345K ﹤0.01% 952
2025
Q2 		$496K Buy
+10,199
New +$395K ﹤0.01% 883

Other funds holding CRSP

AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
OAG
Orbis Allan Gray Hamilton, Bermuda $23.7B AUM 65.43% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
GP
GSK plc London $599M AUM
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

CIBC World Markets's CRSP Position: Q4 2025 in Review

CIBC World Markets opened a new position in CRISPR Therapeutics (CRSP) in Q4 2025: 5,767 shares worth $302K. The stake represents ﹤0.01% of the portfolio and ranks #952 among its holdings. This is a return to the name: CIBC World Markets previously reported a position in CRSP as recently as Q2 2025.

CIBC World Markets first reported a position in CRSP in Q2 2025 and has held it in 2 quarters since. The position peaked at $496K in Q2 2025. 479 funds tracked by Wall St. Rank hold CRSP as of Q4 2025.

  • CIBC World Markets held 5,767 shares of CRISPR Therapeutics worth $302K as of Q4 2025.
  • CRISPR Therapeutics was a new CIBC World Markets position in Q4 2025.
  • CRISPR Therapeutics made up ﹤0.01% of CIBC World Markets's portfolio in Q4 2025, its #952 holding.
  • CIBC World Markets first reported a position in CRISPR Therapeutics in Q2 2025 and has held it in 2 quarters since.
  • CIBC World Markets's CRISPR Therapeutics position peaked at $496K in Q2 2025.
  • 479 funds tracked by Wall St. Rank held CRISPR Therapeutics as of Q4 2025.

Based on CIBC World Markets's 13F filing for Q4 2025, filed 12 Feb 2026.